TNFRSF8 Antikörper (AA 131-230) (Cy7)
Kurzübersicht für TNFRSF8 Antikörper (AA 131-230) (Cy7) (ABIN741096)
Target
Alle TNFRSF8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 131-230
-
Kreuzreaktivität
- Human, Schwein
-
Homologie
- Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CD30
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
-
Andere Bezeichnung
- Cd30
-
Hintergrund
-
Synonyms: CD3, Ki-1, D1S166E, Tumor necrosis factor receptor superfamily member 8, CD3L receptor, Ki-1 antigen, Lymphocyte activation antigen CD3, TNFRSF8
Background: Receptor for TNFSF8/CD3L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B.
-
Gen-ID
- 943
-
UniProt
- P28908
Target
-